Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The safety of hydroquinone.
Nordlund JJ, Grimes PE, Ortonne JP. Nordlund JJ, et al. Among authors: Grimes PE. J Eur Acad Dermatol Venereol. 2006 Aug;20(7):781-7. doi: 10.1111/j.1468-3083.2006.01670.x. J Eur Acad Dermatol Venereol. 2006. PMID: 16898897 Review.
A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen.
Fu JJ, Hillebrand GG, Raleigh P, Li J, Marmor MJ, Bertucci V, Grimes PE, Mandy SH, Perez MI, Weinkle SH, Kaczvinsky JR. Fu JJ, et al. Among authors: Grimes PE. Br J Dermatol. 2010 Mar;162(3):647-54. doi: 10.1111/j.1365-2133.2009.09436.x. Br J Dermatol. 2010. PMID: 20374604 Free PMC article. Clinical Trial.
The safety of hydroquinone.
Nordlund J, Grimes P, Ortonne JP. Nordlund J, et al. Among authors: Grimes P. J Cosmet Dermatol. 2006 Jun;5(2):168-9. doi: 10.1111/j.1473-2165.2006.00244.x. J Cosmet Dermatol. 2006. PMID: 17173592 No abstract available.
A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% cream.
Bhawan J, Grimes P, Pandya AG, Keady M, Byers HR, Guevara IL, Colón LE, Johnson LA, Gottschalk R. Bhawan J, et al. Among authors: Grimes P. Am J Dermatopathol. 2009 Dec;31(8):794-8. doi: 10.1097/DAD.0b013e3181a9070d. Am J Dermatopathol. 2009. PMID: 19755910 Clinical Trial.
Postinflammatory hyperpigmentation.
Taylor S, Grimes P, Lim J, Im S, Lui H. Taylor S, et al. Among authors: Grimes P. J Cutan Med Surg. 2009 Jul-Aug;13(4):183-91. doi: 10.2310/7750.2009.08077. J Cutan Med Surg. 2009. PMID: 19706225 Review.
Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.
Tanghetti E, Dhawan S, Green L, Del Rosso J, Draelos Z, Leyden J, Shalita A, Glaser DA, Grimes P, Webster G, Barnett P, Le Gall N. Tanghetti E, et al. Among authors: Grimes P. J Drugs Dermatol. 2010 May;9(5):549-58. J Drugs Dermatol. 2010. PMID: 20480800 Clinical Trial.
Increasing our understanding of pigmentary disorders.
Grimes P, Nordlund JJ, Pandya AG, Taylor S, Rendon M, Ortonne JP. Grimes P, et al. J Am Acad Dermatol. 2006 May;54(5 Suppl 2):S255-61. doi: 10.1016/j.jaad.2005.12.042. J Am Acad Dermatol. 2006. PMID: 16631966 Review.
A double-blind, randomized, multicenter, controlled trial of suspended polymethylmethacrylate microspheres for the correction of atrophic facial acne scars.
Karnik J, Baumann L, Bruce S, Callender V, Cohen S, Grimes P, Joseph J, Shamban A, Spencer J, Tedaldi R, Werschler WP, Smith SR. Karnik J, et al. Among authors: Grimes P. J Am Acad Dermatol. 2014 Jul;71(1):77-83. doi: 10.1016/j.jaad.2014.02.034. Epub 2014 Apr 13. J Am Acad Dermatol. 2014. PMID: 24725475 Clinical Trial.
65 results
Jump to page
Feedback